WSIDX Performance — Allspring Income Plus Fund, Administrator Class
Data updated: 2026-08-26
WSIDX returned +2.09% year to date and +6.71% over one year to Jun 2026. Annualised returns are +7.20% over 3 years and +4.81% over 5 years. The fund beat its Global Intermediate Core Bond category average: $100 invested three years ago grew to $123, against $118 for the category, and to $107 over one year, against $106. Volatility over the past three years was 4.51% a year. In the 12 months to Jun 2026 the fund lost a net $10.6M, and assets reached $181.32M.
WSIDX Growth of $100
What $100 invested in Allspring Income Plus Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Intermediate Core Bond category average over the same months.
| Period | WSIDX | Category average |
|---|---|---|
| 1 year (Dec 2024 – Jun 2026) | $107 | $106 |
| 3 years (Dec 2022 – Jun 2026) | $123 | $118 |
| 5 years (Dec 2020 – Jun 2026) | $126 | $103 |
| Since data start (Jul 2019 – Jun 2026) | $127 | $111 |
WSIDX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +2.09% |
| 1 year | +6.71% |
| 3 years (annualised) | +7.20% |
| 5 years (annualised) | +4.81% |
WSIDX Annual Returns
Calendar-year total returns of Allspring Income Plus Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Apr–Jun) | +2.09% |
| 2025 (Jan–Aug) | +5.13% |
| 2024 | +5.06% |
| 2023 | +9.09% |
| 2022 | +2.75% |
| 2021 | +0.03% |
| 2020 | +0.08% |
| 2019 (Jul–Dec) | +0.03% |
WSIDX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | — | — | — | +0.9% | +0.8% | +0.4% | — | — | — | — | — | — |
| 2025 | +1.2% | +1.2% | −0.4% | −0.3% | +0.6% | +1.5% | +0.4% | +0.9% | — | — | — | — |
| 2024 | +0.4% | −0.8% | +1.0% | −1.2% | +1.3% | +0.4% | +1.8% | +1.3% | +1.3% | −1.1% | +1.1% | −0.6% |
| 2023 | +3.2% | −1.8% | +0.9% | +0.7% | −0.6% | +0.5% | +0.9% | +0.1% | −1.5% | −1.1% | +4.0% | +3.7% |
| 2022 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +0.1% | +2.6% | +0.1% |
| 2021 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2020 | 0.0% | 0.0% | −0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2019 | — | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
WSIDX Risk
Risk measures from monthly returns over Dec 2022 – Jun 2026.
- 3-year volatility (annualised): 4.51%
- 3-year Sharpe ratio: 0.60 (vs 4.5% risk-free rate)
- Best month: +4.05% (Nov 2023)
- Worst month: −1.75% (Feb 2023)
WSIDX Fund Flows
Monthly money in and out of Allspring Income Plus Fund, from SEC Form N-PORT.
- 12-month net flow: −$10.6M
- 12-month gross sales (incl. reinvestments): $71.3M
- Sales ÷ redemptions: 0.87×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $2.7M | $12.5M | −$9.9M |
| May 2026 | $3.5M | $20.6M | −$17.1M |
| Apr 2026 | $4.1M | $3.3M | $844K |
| Mar 2026 | $6.4M | $12.5M | −$6.1M |
| Feb 2026 | $4.5M | $2.2M | $2.3M |
| Jan 2026 | $7.3M | $3.8M | $3.4M |
| Dec 2025 | $3.4M | $5.3M | −$1.9M |
| Nov 2025 | $5.8M | $8.2M | −$2.4M |
| Oct 2025 | $5.1M | $3.4M | $1.6M |
| Sep 2025 | $7.6M | $4.8M | $2.8M |
| Aug 2025 | $7.1M | $2.9M | $4.1M |
| Jul 2025 | $14.1M | $2.4M | $11.7M |
WSIDX Assets Under Management
Net assets of Allspring Income Plus Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $181.32M |
| 2026-03-31 | $205.75M |
| 2025-12-31 | $209.31M |
| 2025-09-30 | $212.95M |
| 2025-06-30 | $192.54M |
| 2025-03-31 | $159.67M |
| 2024-12-31 | $285.03M |
| 2024-09-30 | $263.57M |
| 2024-06-30 | $272.34M |
| 2024-03-31 | $265.43M |
| 2023-12-31 | $172.53M |
| 2023-09-30 | $158.88M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.